Casirivimab+Imdevimab

· Regeneron Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Casirivimab+Imdevimab, covering 2023-07-24 to 2023-07-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Efficacy and Safety of Casirivimab+Imdevimab (Monoclonal Antibodies) for Prevention of COVID-19 in Immunocompromised Adolescents and Adults [Phase 3]

See pricing